These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 33730376)

  • 41. Determination of antimigraine compounds rizatriptan, zolmitriptan, naratriptan and sumatriptan in human serum by liquid chromatography/electrospray tandem mass spectrometry.
    Vishwanathan K; Bartlett MG; Stewart JT
    Rapid Commun Mass Spectrom; 2000; 14(3):168-72. PubMed ID: 10637423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials.
    Ashcroft DM; Millson D
    Pharmacoepidemiol Drug Saf; 2004 Feb; 13(2):73-82. PubMed ID: 14998068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation between lipophilicity and triptan outcomes.
    Pascual J; Muñoz P
    Headache; 2005 Jan; 45(1):3-6. PubMed ID: 15663606
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Individual triptan selection in migraine attack therapy.
    Belvís R; Pagonabarraga J; Kulisevsky J
    Recent Pat CNS Drug Discov; 2009 Jan; 4(1):70-81. PubMed ID: 19149716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Eletriptan: a review of its use in the acute treatment of migraine.
    McCormack PL; Keating GM
    Drugs; 2006; 66(8):1129-49. PubMed ID: 16789799
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis.
    Cameron C; Kelly S; Hsieh SC; Murphy M; Chen L; Kotb A; Peterson J; Coyle D; Skidmore B; Gomes T; Clifford T; Wells G
    Headache; 2015; 55 Suppl 4():221-35. PubMed ID: 26178694
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The scientific basis of medication choice in symptomatic migraine treatment.
    Goadsby PJ
    Can J Neurol Sci; 1999 Nov; 26 Suppl 3():S20-6. PubMed ID: 10563229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Migraine pharmacotherapy with oral triptans: a rational approach to clinical management.
    Millson DS; Tepper SJ; Rapoport AM
    Expert Opin Pharmacother; 2000 Mar; 1(3):391-404. PubMed ID: 11249525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Zolmitriptan].
    Monseu G; Sternon J
    Rev Med Brux; 1998 Dec; 19(6):495-9. PubMed ID: 9916496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Formulation Approaches of Triptans for Management of Migraine.
    Kassem AA
    Curr Drug Deliv; 2016; 13(6):882-98. PubMed ID: 27109335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Triptans other than sumatriptan in child and adolescent migraine: literature review.
    Vollono C; Vigevano F; Tarantino S; Valeriani M
    Expert Rev Neurother; 2011 Mar; 11(3):395-401. PubMed ID: 21375444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability.
    Pascual J; Mateos V; Roig C; Sanchez-Del-Rio M; Jiménez D
    Headache; 2007 Sep; 47(8):1152-68. PubMed ID: 17883520
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eletriptan review.
    Färkkilä M; Kallela M
    Expert Opin Pharmacother; 2005 Apr; 6(4):625-30. PubMed ID: 15934888
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and validation of a liquid chromatography-tandem mass spectrometric assay for quantitative analyses of triptans in hair.
    Vandelli D; Palazzoli F; Verri P; Rustichelli C; Marchesi F; Ferrari A; Baraldi C; Giuliani E; Licata M; Silingardi E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr; 1017-1018():136-144. PubMed ID: 26970848
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Triptans and CNS side-effects: pharmacokinetic and metabolic mechanisms.
    Dodick DW; Martin V
    Cephalalgia; 2004 Jun; 24(6):417-24. PubMed ID: 15154851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The efficacy of triptans in childhood and adolescence migraine.
    Evers S
    Curr Pain Headache Rep; 2013 Jul; 17(7):342. PubMed ID: 23709234
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coprescription of triptans with potentially interacting medications: a cohort study involving 240,268 patients.
    Tepper S; Allen C; Sanders D; Greene A; Boccuzzi S
    Headache; 2003 Jan; 43(1):44-8. PubMed ID: 12864757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drugs for the acute treatment of migraine in children and adolescents.
    Richer L; Billinghurst L; Linsdell MA; Russell K; Vandermeer B; Crumley ET; Durec T; Klassen TP; Hartling L
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD005220. PubMed ID: 27091010
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Double-blind clinical trials of oral triptans vs other classes of acute migraine medication - a review.
    Lipton RB; Bigal ME; Goadsby PJ
    Cephalalgia; 2004 May; 24(5):321-32. PubMed ID: 15096220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Using patient-centered endpoints to determine the cost-effectiveness of triptans for acute migraine therapy.
    Kelman L; Von Seggern RL
    Am J Ther; 2006; 13(5):411-7. PubMed ID: 16988536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.